NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,396,000 | -1.0% | 713,769 | -6.5% | 3.53% | +5.8% |
| Q1 2019 | $25,650,000 | +6.9% | 763,403 | +4.5% | 3.33% | -12.9% |
| Q4 2018 | $24,003,000 | +5.7% | 730,226 | +96.0% | 3.83% | +4.4% |
| Q3 2018 | $22,711,000 | +24.3% | 372,551 | -0.5% | 3.66% | +28.8% |
| Q2 2018 | $18,275,000 | -42.7% | 374,251 | +24.7% | 2.84% | -59.4% |
| Q1 2018 | $31,887,000 | +51.8% | 300,086 | -14.7% | 7.00% | +21.6% |
| Q4 2017 | $21,006,000 | +73.9% | 351,741 | -30.1% | 5.76% | +50.6% |
| Q3 2017 | $12,077,000 | +31.4% | 503,193 | +7.0% | 3.82% | +24.0% |
| Q2 2017 | $9,192,000 | +75.3% | 470,194 | +110.5% | 3.08% | +54.0% |
| Q1 2017 | $5,244,000 | – | 223,421 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |